| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(87)91980-5 |
| P698 | PubMed publication ID | 2879982 |
| P2093 | author name string | H Yabuuchi | |
| E Franco | |||
| S Doi | |||
| S Ishihara | |||
| A Tawa | |||
| K Kawa-Ha | |||
| K Yumura | |||
| P2860 | cites work | Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies | Q34467589 |
| The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes | Q41998611 | ||
| Chronic, symptomatic Epstein-Barr virus infections | Q45344642 | ||
| Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome | Q45798932 | ||
| Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivatedin vitro | Q45805450 | ||
| Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer | Q45838966 | ||
| Deficient Natural Killer Cell Activity in X-Linked Lymphoproliferative Syndrome | Q72619059 | ||
| P433 | issue | 8525 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| Epstein–Barr virus | Q6900 | ||
| P304 | page(s) | 154 | |
| P577 | publication date | 1987-01-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2. | |
| P478 | volume | 1 |
| Q33362585 | A case of severe chronic active Epstein-Barr virus infection with T-cell lymphoproliferative disorder |
| Q44675423 | Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection |
| Q45783530 | Budd-Chiari syndrome and Epstein-Barr virus (EBV) associated plasmacytoma in a patient with chronic active EBV infection |
| Q34576305 | CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA |
| Q24617384 | Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States |
| Q34522500 | Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation |
| Q40553142 | Clinical effects of infusing anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection |
| Q45142119 | Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection |
| Q44174866 | Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites |
| Q45721973 | Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases |
| Q59128393 | Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders |
| Q89661292 | Intracranial Epstein-Barr virus infection appearing as an unusual case of meningitis in an immunocompetent woman: a case report |
| Q40716342 | Isolation of human herpesvirus 7 from a child with symptoms mimicking chronic Epstein-Barr virus infection |
| Q24657703 | Optimal treatment for chronic active Epstein-Barr virus disease |
| Q35017877 | Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome |
| Q45842150 | Remarkable depression of CD4+2H4+ T cells in severe chronic active Epstein-Barr virus infection |
| Q36636997 | Severe chronic active Epstein-Barr virus infection syndrome |
| Q42166934 | Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansion |
| Q41412514 | Therapeutic approaches for severe Epstein-Barr virus infection |
Search more.